Articles

Americans for Safe Access, the nation’s largest member-based organization promoting safe access to medical cannabis, recently released a detailed report on how disparities in state cannabis testing programs affect the health of patients.

How Testing Inconsistencies Affect Medical Cannabis Patients: A Webinar on a Special Report from Americans for Safe Access

Madeline Colli is the Associate Editor for Cannabis Patient Care and Cannabis Science and Technology magazines at MJH Life Sciences.

Mental Health Options, an advocacy group based in Massachusetts, has filed paperwork to list psychedelic decriminalization as a ballot question for voters.

Massachusetts Advocacy Group Files to List Psychedelic Decriminalization Question on Ballots

North Carolina State House Speaker, Tim Moore, announced that a medical cannabis legalization bill which would have benefitted many, such as veterans, is unlikely to pass in 2023.

Veterans Grow Frustrated After Hearing Medical Cannabis Legalization May Not Pass in 2023

A Brazilian university has detected cannabidiol (CBD) in a native plant called Trema micrantha blume.

Brazilian Plant Found to Contain CBD

Our sister publication, CURE, recently spoke with Kim Stuck, breast cancer survivor and author of the Cannabis Science and Technology blog Stuck on Compliance.

Survivor Says Cannabis Use ‘Was the Best Thing’ During Cancer

New Hampshire allows out-of-state visitors, including those from Canada, to buy medical cannabis.

New Hampshire Begins to Allow Out-of-State Visitors to Purchase Medical Cannabis

Arkansas medical cannabis retailers reported increased product volume and sales within the first 6 months of the year.

Medical Cannabis Sales in Arkansas Reach $141 Million in First Half of 2023

To help the mental health of citizens and soldiers, the president of Ukraine called for more support for medical cannabis legalization in the country.

Ukraine President Calls for Medical Cannabis Legalization to Address Mental Health Challenges

The FDA issued first draft guidance on clinical trials with psychedelic drugs.

FDA Unveils First Draft Guidance on Psychedelic Drug Clinical Trials

Toms Shoes founder promises $100 million towards psychedelic research and access.

All News